Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs ETHSX overlap: 64% of top holdings shared

Bottom line

How much do PRHSX and ETHSX overlap?

64% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 52.2% of PRHSX's assets and 57.9% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXETHSX
Weight overlap (top 25)64%
Shared holdings13
Weight in shared holdings52.2%57.9%
Total positions27942
Expense ratio0.83%1.18%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings PRHSX and ETHSX have in common

Holding% of PRHSX% of ETHSXOverlap
Eli Lilly & Co14.28%12.47%12.47%
Johnson & Johnson6.63%6.45%6.45%
Unitedhealth Group Inc5.99%5.49%5.49%
Abbvie Inc5.10%6.46%5.10%
Merck & Co. Inc.4.01%5.08%4.01%
Gilead Sciences Inc2.82%3.34%2.82%
Thermo Fisher Scientific Inc2.52%2.79%2.52%
Vertex Pharmaceuticals Inc2.28%3.38%2.28%
Bristol-myers Squibb Co2.11%4.25%2.11%
Abbott Laboratories1.89%1.65%1.65%
Intuitive Surgical Inc1.87%2.72%1.87%
Stryker Corp1.78%2.21%1.78%
Royalty Pharma Plc- Cl A0.97%1.58%0.97%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Amgen Inc — 1.82%
  2. Elevance Health Inc — 1.53%
  3. Natera Inc — 1.44%
  4. Danaher Corp — 1.43%
  5. Guardant Health Inc — 1.23%
  6. Cardinal Health Inc — 1.03%
  7. Cvs Health Corp — 0.94%
  8. Tenet Healthcare Corp — 0.94%
  9. Kymera Therapeutics Inc — 0.89%
  10. Protagonist Therapeutics Inc — 0.85%
  11. Moderna Therapeutics Inc — 0.83%
  12. Brightspring Health Services — 0.82%

Only in ETHSX

  1. AstraZeneca PLC — 6.24%
  2. Roche Holding AG — 5.44%
  3. Sanofi SA — 2.95%
  4. Boston Scientific Corp — 2.18%
  5. Medtronic PLC — 1.80%
  6. Lonza Group AG — 1.77%
  7. Novo Nordisk A/S — 1.71%
  8. Novartis AG — 1.65%
  9. Argenx SE — 1.61%
  10. Neurocrine Biosciences Inc — 1.41%
  11. Mettler-Toledo International Inc — 1.36%
  12. Straumann Holding AG — 1.34%

Asset mix

Asset typePRHSXETHSX
Stocks96.4%99.4%
Preferred stock3.0%—
Cash & short-term funds0.7%0.3%
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryPRHSXETHSX
US92.6%69.4%
CH0.5%10.2%
GB1.7%7.8%
FR0.2%3.2%
DK0.7%2.9%
NL1.0%2.0%
IE0.8%1.8%
AU—0.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PRHSX and ETHSX overlap?
About 64% by weight. 13 securities appear in both funds' top 25 holdings; they make up 52.2% of PRHSX's assets and 57.9% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and ETHSX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Unitedhealth Group Inc, Abbvie Inc, Merck & Co. Inc..
Should I own both PRHSX and ETHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or ETHSX?
PRHSX is broader, with 279 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.